MOTS-c Mechanism of Action — Research Reference
Mitochondrial-derived peptide biology, AMPK activation, folate-cycle interaction, and the exercise-mimetic signalling that defines MOTS-c in research.
MOTS-c Mechanism of Action — Research Reference
MOTS-c (Mitochondrial Open Reading frame of the Twelve S rRNA-c) is a 16-amino-acid peptide encoded within the mitochondrial genome — specifically the 12S rRNA gene. It is the most-studied member of the mitochondrial-derived peptide (MDP) family.
Origin and Translation
MOTS-c is translated from a short open reading frame inside mitochondrial DNA using the mitochondrial genetic code, then released into circulation. Endogenous plasma levels decline with age and rise acutely with exercise.
Primary Mechanism — AMPK Activation
MOTS-c's defining mechanism is activation of AMP-activated protein kinase (AMPK), achieved indirectly through interference with the folate-methionine cycle:
- MOTS-c reduces flux through the folate cycle, lowering purine and AICAR availability.
- AICAR accumulation activates AMPK (the classic mechanism of metformin).
- AMPK activation drives glucose uptake (GLUT4 translocation), fatty-acid oxidation, mitochondrial biogenesis (via PGC-1α), and autophagy.
Nuclear Translocation
Published work documents MOTS-c translocation to the nucleus under metabolic stress, where it modulates transcription of antioxidant-response and stress-protection genes including NRF2-pathway targets — a second-tier mechanism distinct from cytoplasmic AMPK activation.
Exercise-Mimetic Signature
In rodent models, MOTS-c administration reproduces several molecular signatures of exercise: GLUT4 upregulation in skeletal muscle, improved insulin sensitivity, enhanced exercise capacity, and resistance to diet-induced obesity. This has framed MOTS-c as an "exercise-mimetic peptide" in published reviews.
Distinction from SS-31
SS-31 (elamipretide) binds cardiolipin on the inner mitochondrial membrane and stabilizes electron-transport chain architecture. MOTS-c is a soluble signalling peptide that acts via AMPK and nuclear gene expression. The two are mechanistically distinct despite both being studied in mitochondrial-research contexts.
Research Use Only. All content is for laboratory research and educational reference. Compounds discussed are not intended for human or veterinary consumption.
References
- Lee C, Zeng J, Drew BG, et al. The mitochondrial-derived peptide MOTS-c promotes metabolic homeostasis. Cell Metab. 2015;21(3):443–454.
- Reynolds JC, Lai RW, Woodhead JST, et al. MOTS-c is an exercise-induced mitochondrial-encoded regulator of age-dependent physical decline. Nat Commun. 2021;12(1):470.
- Kim KH, Son JM, Benayoun BA, Lee C. The Mitochondrial-Encoded Peptide MOTS-c Translocates to the Nucleus to Regulate Nuclear Gene Expression. Cell Metab. 2018;28(3):516–524.
Related Research Materials
Parent Research Hubs
Related Research Articles
Semaglutide Mechanism of Action — Receptor, Signalling & Pharmacokinetics
Receptor pharmacology of the long-acting GLP-1 receptor agonist semaglutide: binding affinity, downstream Gαs/cAMP/PKA signalling, gastric emptying, central appetite circuits and albumin-anchored PK.
Tirzepatide Mechanism of Action — Dual GIP/GLP-1 Receptor Pharmacology
Receptor pharmacology of the dual GIP/GLP-1 receptor agonist tirzepatide: imbalanced agonism, downstream signalling differences from semaglutide, and the metabolic consequences of GIP arm activation.
BPC-157 Mechanism of Action — Angiogenesis, NO Pathway & Growth Factor Crosstalk
Proposed mechanisms of stable gastric pentadecapeptide BPC-157: VEGFR2 phosphorylation, nitric oxide pathway modulation, growth-factor crosstalk and gastrointestinal cytoprotection.